The IP Driven Start-up copertina

The IP Driven Start-up

The IP Driven Start-up

Di: Marks & Clerk
Ascolta gratuitamente

Essential topics for the rising stars of the start-up community Economia Gestione e leadership Leadership
Episodi
  • Episode 3: Why deep-tech ventures can fail - and the framework that explains it

    Episode 3: Why deep-tech ventures can fail - and the framework that explains it
    Mar 10 2026
    In this episode, Marks & Clerk's Anis Naidu is joined by Dr. Uday Phadke and Sam Dods, co-founders of Triple Chasm. Drawing on research across 7,000 companies globally, Uday and Sam have built a rigorous, data-driven framework for understanding why so many technology ventures fail to make the journey from laboratory to commercial success - and what the successful ten per cent consistently do differently.
    Mostra di più Mostra meno
    30 min
  • Episode 2: What investors really look for — and the IP mistakes that can cost start-ups their chance

    Episode 2: What investors really look for — and the IP mistakes that can cost start-ups their chance
    Mar 10 2026
    In this episode, Marks & Clerk's Anis Naidu is joined by two of the North West's most experienced voices in early-stage investment and innovation: Dr. Andy Round, Senior Investment Director at Deepbridge Capital, and Andy Roberts, former Head of Innovation at Bruntwood SciTech. Between them, they bring decades of experience backing, advising and accelerating life science start-ups.
    Mostra di più Mostra meno
    25 min
  • Episode 1: From lab to market - the real story of commercialising university research

    Episode 1: From lab to market - the real story of commercialising university research
    Mar 10 2026
    In this episode, Marks & Clerk's Anis Naidu sits down with Professor Aline Miller, Associate Vice President for Enterprise at the University of Manchester and founder of Manchester BIOGEL, which raised over £4 million, built a global distribution network, and achieved a successful exit in 2023. Now developing her second venture, Molla Pharm, Aline offers a thoughtful reflection on a decade of commercialising university research, speaking with the clarity and candour that come from firsthand experience.
    Mostra di più Mostra meno
    32 min
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione